Tags

Type your tag names separated by a space and hit enter

Management of menstrual migraine: a review of current abortive and prophylactic therapies.
Curr Pain Headache Rep. 2010 Oct; 14(5):376-84.CP

Abstract

After menarche, women have an increased prevalence of migraine compared to men. There is significant variability in the frequency and severity of migraine throughout the menstrual cycle. Women report migraines occur more frequently during menses, and that those are more severe than other migraines. This creates a unique challenge of effectively treating menstrually related and pure menstrual migraines. As with treatment of other migraines, both abortive and prophylactic treatment regimens are used. Triptans demonstrate efficacy in the abortive management of menstrually related and pure menstrual migraines. For migraines that occur primarily during menses or that are particularly resistant to other therapies, intermittent prophylactic therapies can be used. Naproxen and estrogens have been studied for this use. More recently, triptans have been examined and have shown efficacy for intermittent prophylaxis of menstrual migraine.

Authors+Show Affiliations

Wake Forest University Health Sciences, Medical Center Boulevard, Winston Salem, NC 27157, USA.No affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

20697846

Citation

Sullivan, Elizabeth, and Cheryl Bushnell. "Management of Menstrual Migraine: a Review of Current Abortive and Prophylactic Therapies." Current Pain and Headache Reports, vol. 14, no. 5, 2010, pp. 376-84.
Sullivan E, Bushnell C. Management of menstrual migraine: a review of current abortive and prophylactic therapies. Curr Pain Headache Rep. 2010;14(5):376-84.
Sullivan, E., & Bushnell, C. (2010). Management of menstrual migraine: a review of current abortive and prophylactic therapies. Current Pain and Headache Reports, 14(5), 376-84. https://doi.org/10.1007/s11916-010-0138-2
Sullivan E, Bushnell C. Management of Menstrual Migraine: a Review of Current Abortive and Prophylactic Therapies. Curr Pain Headache Rep. 2010;14(5):376-84. PubMed PMID: 20697846.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Management of menstrual migraine: a review of current abortive and prophylactic therapies. AU - Sullivan,Elizabeth, AU - Bushnell,Cheryl, PY - 2010/8/11/entrez PY - 2010/8/11/pubmed PY - 2011/8/4/medline SP - 376 EP - 84 JF - Current pain and headache reports JO - Curr Pain Headache Rep VL - 14 IS - 5 N2 - After menarche, women have an increased prevalence of migraine compared to men. There is significant variability in the frequency and severity of migraine throughout the menstrual cycle. Women report migraines occur more frequently during menses, and that those are more severe than other migraines. This creates a unique challenge of effectively treating menstrually related and pure menstrual migraines. As with treatment of other migraines, both abortive and prophylactic treatment regimens are used. Triptans demonstrate efficacy in the abortive management of menstrually related and pure menstrual migraines. For migraines that occur primarily during menses or that are particularly resistant to other therapies, intermittent prophylactic therapies can be used. Naproxen and estrogens have been studied for this use. More recently, triptans have been examined and have shown efficacy for intermittent prophylaxis of menstrual migraine. SN - 1534-3081 UR - https://www.unboundmedicine.com/medline/citation/20697846/Management_of_menstrual_migraine:_a_review_of_current_abortive_and_prophylactic_therapies_ L2 - https://dx.doi.org/10.1007/s11916-010-0138-2 DB - PRIME DP - Unbound Medicine ER -